Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2006-5-31
pubmed:abstractText
gammadelta T cells account for up to 10% of T lymphocytes in the peripheral blood of healthy donors. They can be activated by cytokines such as interleukin (IL)-2, IL-12 and IL-15, express natural killer (NK) cell markers such as NKG2D and show cytotoxic activity against several tumour cells, including multiple myeloma. Here, we present activated polyclonal gammadelta T cells from healthy donors with an NK T cell-like phenotype expressing the natural cytotoxicity receptor NKp44. Natural cytotoxicity receptors NKp30, NKp44 and NKp46 have been regarded as specific NK receptors; only two gammadelta T cell clones described so far expressed NKp 44. Isolated polyclonal gammadelta T cells cultured for 7 days according to the cytokine-induced killer cell (CIK) protocol with additional IL-15 revealed a surface expression of NKp44 of 8+/-7% (n=22). This could be confirmed by detection of NKp 44 mRNA by reverse transcription-polymerase chain reaction (RT-PCR). gammadelta T cells exhibited a marked cytotoxic activity against myeloma cells, which could be reduced by inhibition of NKp44. To our knowledge, this is the first description of the expression of NKp44 on polyclonal gammadelta T cells.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/16734623-10049942, http://linkedlifedata.com/resource/pubmed/commentcorrection/16734623-10090953, http://linkedlifedata.com/resource/pubmed/commentcorrection/16734623-10359807, http://linkedlifedata.com/resource/pubmed/commentcorrection/16734623-10397734, http://linkedlifedata.com/resource/pubmed/commentcorrection/16734623-10426993, http://linkedlifedata.com/resource/pubmed/commentcorrection/16734623-10426994, http://linkedlifedata.com/resource/pubmed/commentcorrection/16734623-10562324, http://linkedlifedata.com/resource/pubmed/commentcorrection/16734623-10887096, http://linkedlifedata.com/resource/pubmed/commentcorrection/16734623-11023518, http://linkedlifedata.com/resource/pubmed/commentcorrection/16734623-11491531, http://linkedlifedata.com/resource/pubmed/commentcorrection/16734623-11536166, http://linkedlifedata.com/resource/pubmed/commentcorrection/16734623-11544298, http://linkedlifedata.com/resource/pubmed/commentcorrection/16734623-11567106, http://linkedlifedata.com/resource/pubmed/commentcorrection/16734623-11602408, http://linkedlifedata.com/resource/pubmed/commentcorrection/16734623-11673519, http://linkedlifedata.com/resource/pubmed/commentcorrection/16734623-12384702, http://linkedlifedata.com/resource/pubmed/commentcorrection/16734623-12414645, http://linkedlifedata.com/resource/pubmed/commentcorrection/16734623-12538656, http://linkedlifedata.com/resource/pubmed/commentcorrection/16734623-12623838, http://linkedlifedata.com/resource/pubmed/commentcorrection/16734623-12714493, http://linkedlifedata.com/resource/pubmed/commentcorrection/16734623-14707061, http://linkedlifedata.com/resource/pubmed/commentcorrection/16734623-15328155, http://linkedlifedata.com/resource/pubmed/commentcorrection/16734623-15894118, http://linkedlifedata.com/resource/pubmed/commentcorrection/16734623-1711560, http://linkedlifedata.com/resource/pubmed/commentcorrection/16734623-3926660, http://linkedlifedata.com/resource/pubmed/commentcorrection/16734623-4097745, http://linkedlifedata.com/resource/pubmed/commentcorrection/16734623-6042436, http://linkedlifedata.com/resource/pubmed/commentcorrection/16734623-8152260, http://linkedlifedata.com/resource/pubmed/commentcorrection/16734623-8200042, http://linkedlifedata.com/resource/pubmed/commentcorrection/16734623-8599969, http://linkedlifedata.com/resource/pubmed/commentcorrection/16734623-9625766, http://linkedlifedata.com/resource/pubmed/commentcorrection/16734623-9730896, http://linkedlifedata.com/resource/pubmed/commentcorrection/16734623-9973456
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0009-9104
pubmed:author
pubmed:issnType
Print
pubmed:volume
144
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
528-33
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:16734623-Cells, Cultured, pubmed-meshheading:16734623-Cytotoxicity, Immunologic, pubmed-meshheading:16734623-Gene Expression Regulation, pubmed-meshheading:16734623-Humans, pubmed-meshheading:16734623-Immunophenotyping, pubmed-meshheading:16734623-Interleukin-15, pubmed-meshheading:16734623-Interleukin-2, pubmed-meshheading:16734623-Killer Cells, Natural, pubmed-meshheading:16734623-Lymphocyte Activation, pubmed-meshheading:16734623-Multiple Myeloma, pubmed-meshheading:16734623-Natural Cytotoxicity Triggering Receptor 2, pubmed-meshheading:16734623-RNA, Messenger, pubmed-meshheading:16734623-Receptors, Antigen, T-Cell, gamma-delta, pubmed-meshheading:16734623-Receptors, Immunologic, pubmed-meshheading:16734623-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:16734623-Tumor Cells, Cultured
pubmed:year
2006
pubmed:articleTitle
Activated gammadelta T cells express the natural cytotoxicity receptor natural killer p 44 and show cytotoxic activity against myeloma cells.
pubmed:affiliation
Medizinische Klinik und Poliklinik I, Universitätsklinikum Bonn, Sigmund Freud Str. 25, 53105 Bonn, Germany. m.lilienfeld.toal@uni-bonn.de
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't